top of page

Search Results

Search results for "Gator Bio"

Results found for "Gator Bio"

  • Dr. Peter Robert Banks | Dr. GPCR Ecosystem

    Peter Robert Banks Peter Banks is currently the Scientific Director at BioTek Instruments , now a part Before joining BioTek in 2008, Banks was employed by PerkinElmer for a decade. These roles included management of PerkinElmer’s BioPharma R&D program and Chair of the company’s Scientific Prior to experiences at PerkinElmer and BioTek, Banks was an Assistant Professor in Analytical Chemistry

  • Media Partner Packages | Dr. GPCR Ecosystem

    As a strtegic partner, you'll gain trusted access to an engaged audience of academic researchers, biotech partner, you'll be featured across our nonprofit platform, trusted by thousands of GPCR scientists and biotech Social Media Promotion âś“ Engaging posts about your organization âś“ Targeted to GPCR researchers and biotech

  • Dr. Shivani Sachdev | Dr. GPCR Ecosystem

    She received her undergraduate degree in Biotechnology from KIIT University in India.

  • Dr. Richard Premont | Dr. GPCR Ecosystem

    Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, and M.Ph . and Ph.D. in Biomedical Sciences (Pharmacology) at Mount Sinai School of Medicine (City University In our work, we utilize methods including structural biology and proteomics, molecular biology and biochemical

  • Model. Predict. Discover. with Dr. Jens Carlsson | Dr. GPCR Ecosystem

    Jens Carlsson, Professor of Computational Biochemistry at Uppsala University, joins Dr. Early-career researchers exploring drug discovery Biotech leaders and R&D strategists Anyone interested in predictive modeling, AI in biology, or structure-function relationships About Jens Carlsson Jens Carlsson is a Professor of Computational Biochemistry at Uppsala University, where his research group Trained initially as a biotechnology engineer, Jens discovered his true calling during an internship

  • Dr. Khaled Abdelrahman, Victoria Rasmussen and Madelyn Moore | Dr. GPCR Ecosystem

    She completed her undergraduate education at Providence College, receiving a B.S. in Biology and a B.A Victoria started her Ph.D. at the Tri-Institutional Ph.D. program in Chemical Biology, where she joined as a therapeutic strategy. " Victoria Rasmussen on the web Tri-Institutional PhD Program in Chemical Biology GPCR About Madelyn Moore "Madelyn (Maddi) earned her B.S. in Biochemistry from the University of Minnesota-Duluth

  • GPCR Retreat | Dr. GPCR Ecosystem

    investigators from academia and industry to discuss and debate existing and novel concepts in GPCR biology

  • Charlotte Crauwels: Designing Hybrid GPCRs with Computational Protein Engineering | Dr. GPCR Ecosystem

    Her work integrates bioinformatics, protein modeling, and experimental collaboration to support GPCR GPCR Biology Continues to Produce “Gotcha Moments” Despite decades of research, GPCRs remain complex How bioengineering and bioinformatics led Dr. I studied bioengineering in Brussels, and during my master’s I was introduced to bioinformatics. How do you see the role of computational approaches in GPCR biology?

  • Kari Johnson: mGlu2, Addiction, and the Brain Circuits Alcohol Rewires | Dr. GPCR Ecosystem

    made the shift to optogenetics and genetically defined neuronal populations specifically because the biology A circuit-level argument 33:12 Advice for junior scientists: let the biology lead the method 35:28 Diversity

  • Dr. AurĂ©lien Rizk | Dr. GPCR Ecosystem

    He is Chief Scientific Officer and co-founder of InterAx Biotech, where he specializes in the development He also worked on creating novel methods for systems biology using temporal logic specifications while conversation about the importance of merging mathematical models and biology. his experiences transitioning from academia into the biotech sector. and relevance of mathematical models in systems biology and pharmacology.

  • Dr. Tobi Langenhan | Dr. GPCR Ecosystem

    For my doctoral studies, I joined the lab of Dr Andreas Russ at the Department of Biochemistry and first recruited to the Medical Faculty of Leipzig University, where I now head the Department of General Biochemistry

  • Receptor Signaling Bias: A Valuable and Accessible Property of New Drug Candidates | Dr. GPCR Ecosystem

    This webinar explains the biological basis of signaling bias, shows how to detect and quantify it using The Biology Behind Bias Ligands produce differential pathway engagement at a single receptor because testing, and backed by thousands of peer-reviewed publications and partnerships with leading pharma and biotech intelligence, expert-led masterclasses, and structured engagement opportunities for scientists and biotech Expert-led webinars and masterclasses with leading researchers Structured networking for scientists and biotech

  • Ross Cheloha: Nanobody-GPCR Conjugates and the Engineering of Receptor Selectivity | Dr. GPCR Ecosystem

    Ross Cheloha approaches these questions from a chemical biology perspective - using synthetic peptide His research combines peptide chemistry, chemical biology, and nanobody engineering to build mechanistic on the parathyroid hormone receptor and its downstream consequences for calcium homeostasis and bone biology The biology may have been using this distinction all along: two natural ligands for the same receptor Ross Cheloha is an Investigator at the National Institutes of Health in the Laboratory of Bioorganic

  • GPCR location matters with Dr. Gabriele Kockelkoren | Dr. GPCR Ecosystem

    Gabriele Kockelkoren About Gabriele Kockelkoren I have a strong background in both physics and molecular biology

  • Dr. Kenneth A. Jacobson | Dr. GPCR Ecosystem

    is currently the Senior Investigator and Chief of the Molecular Recognition Section, Laboratory of Bioorganic

  • Dr. Silvia Sposini | Dr. GPCR Ecosystem

    Silvia Sposini " I'm originally from Rome, Italy, where I studied Biological Sciences as a BSc student

  • Murat Tunaboylu & Ben Holland | Dr. GPCR Ecosystem

    Ben Holland About Murat Tunaboylu "Murat Tunaboylu, Antiverse's CEO, has a software engineering and bioinformatics After switching to biotech, Murat has built cell imaging software and lab robots to accelerate cancer He has co-founded consultancy and biotech companies Svarlight and Antiverse. Murat Tunaboylu on the web Antiverse DSV Future of Drug Discovery Podcast Twist Bioscience LinkedIn Twitter

  • Arun Shukla: How Two Arrestins Regulate 800 GPCRs | Dr. GPCR Ecosystem

    Arun Shukla leads a structural pharmacology lab in the Department of Biological Sciences and Bioengineering He completed his PhD at the Max Planck Institute of Biophysics in Frankfurt and postdoctoral training Episode Timeline 00:00 Introduction 02:15 From DNA quadruplexes to GPCR structural biology 06:32 The Sciences and Bioengineering. a biochemistry class where he learned about cell signaling that he became curious and wanted to learn

  • Dr. Marta Filizola | Dr. GPCR Ecosystem

    Neuroscience, and Artificial Intelligence and Human Health, as well as the Dean of The Graduate School of Biomedical To this end, her lab uses several computational structural biology tools and rational drug design approaches , ranging from molecular modeling, bioinformatics, cheminformatics, molecular dynamics simulations, free-energy in Computational Chemistry at the Second University of Naples and a postdoctorate in Computational Biophysics

  • GPCRs and the Science Behind Pain and Recovery with Dr. Alex Serafini | Dr. GPCR Ecosystem

    Pain became more than biology — it became a personal strategy. At one point, he had a job offer at Roivant (a biotech firm known for repurposing shelved compounds), approach, though less common, could help pain research finally catch up with the complexity of real-world biology

  • Bryan Roth: Inside the DARPA Bet on a Non-Psychedelic Psychedelic | Dr. GPCR Ecosystem

    non-psychedelic psychedelic for depression — and why the real bottleneck in GPCR drug discovery is the biology He earned his MD and biochemistry PhD at St. Louis University and trained in pharmacology at NIH and in molecular biology and psychiatry at Stanford It reframes the field's task from finding good targets to understanding the biology well enough to connect After receiving his MD and Ph.D. in Biochemistry from St.

  • Dr. Neil Grimsey | Dr. GPCR Ecosystem

    We have developed an array of fluorescent biosensors to map kinase activity in living cells and are exploring

  • Brian Arey - Part 2: GPCR Drug Discovery and the Science Nobody Publishes | Dr. GPCR Ecosystem

    endothelial cells, cardiovascular target validation, thrombosis pharmacology, and metabolic disease biology drug discovery is grounded in classical physiology and driven by a willingness to enter fields - bone biology His belief in the biology has not changed. professional cost that nobody warns you about Moving between neuroscience, reproductive endocrinology, bone biology contributed to the discovery or development of 5 marketed drugs through his work spanning molecular, biochemical

  • From Curiosity to Breakthrough: Ajay Yekkirala on GPCR Innovation | Dr. GPCR Ecosystem

    Biotech founder Ajay Yekkirala shares how AI, GPCRs, and bold questions are driving next-gen pain therapeutics Ajay Yekkirala is a GPCR pharmacologist, biotech entrepreneur, and co-founder of Superluminal Medicines AI is reshaping how we understand protein dynamics , but only when driven by deep biological questions GPCR scientists interested in translational innovation Biotech investors and strategic leaders seeking Ajay’s work sits at the intersection of GPCR biology, AI, and translational medicine.

  • Dr. Patrick Sexton | Dr. GPCR Ecosystem

    2021 Clarivate Analytics Highly Cited Researcher in two disciplines: Pharmacology & Toxicology and Biology & Biochemistry, a corresponding member of the International Union of Basic and Clinical Pharmacology Sexton is also a co-founder of the San Francisco-based biotechnology company Septerna Inc . Dr.

  • Developing new tools to uncover GPCR signaling patterns with Remi Janicot | Dr. GPCR Ecosystem

    This research has led to a first-author Cell article on the development of a new biosensor platform called ONE-GO biosensors.

  • Dr. David Sykes | Dr. GPCR Ecosystem

    David Sykes " David Andrew Sykes, BSc Hons Pharmacology, MSc Molecular Biology and Biochemistry, PhD

  • Dr. GPCR Ecosystem

    Biotech Decision Vault by Attila Foris Strategic Business & Operating Systems Advisor Dr.

  • Graciela Piñeyro: Partial Agonism, Receptor Recycling, and the Limits of Bias | Dr. GPCR Ecosystem

    trafficking and recycling, and more recently the cannabinoid entourage hypothesis — combining BRET-based biosensors receptor tone Quantitative pharmacology as rescue operation — using operational models and BRET-based biosensors mechanistic story that guided a decade of biased-ligand drug discovery needs rebuilding from the underlying biology

  • About Dr. GPCR Ecosystem | Uniting the GPCR Community to Advance Drug Discovery

    GPCR was created to break down barriers across academia, biotech, pharma, and CROs—so knowledge, tools field , including: Academic researchers (PI, postdoc, student) Industry scientists and R&D leaders Biotech

bottom of page